NASDAQ · Biotechnology
Novavax Inc (NVAX)
$7.47
-3.24%
33
In band
Moving averages
SMA 200$9.34-20.02%
Company profile
Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.
SectorHealthcare
IndustryBiotechnology
Market cap$1.65B
P/E ratioNone
EPS$-0.51
Beta2.72
Dividend yield0.00%
52-week high$13.39
52-week low$6.20
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
NTLA
Intellia Therapeutics Inc
RSI 37
SRPT
Sarepta Therapeutics Inc
RSI 29
GPCR
Structure Therapeutics Inc
RSI 25
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
GHRS
GH Research PLC
RSI 41
AUPH
Aurinia Pharmaceuticals Inc
RSI 32
RSI alerts for NVAX
An email when NVAX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 1:26 AM EST